Antibacterial Activity of the Novel Drug Gepotidacin against <i>Stenotrophomonas maltophilia</i>-An In Vitro and In Vivo Study

• Główni autorzy: Maike Isabell Sanders (Autor), Eyhab Ali (Autor), Jan Buer (Autor), Joerg Steinmann (Autor), Peter-Michael Rath (Autor), Hedda Luise Verhasselt (Autor), Lisa Kirchhoff (Autor)
• Format: Książka
• Wydane: MDPI AG, 2022-02-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

<i>Stenotrophomonas maltophilia</i> is increasingly recognized as a nosocomial bacterial pathogen with a multi-drug resistance profile. In this study, the novel drug gepotidacin, the first compound of the novel triazaacenaphthylene topoisomerase inhibitor antibiotics class, was evaluated...